Skip to main content
. 2005 Mar 21;11(11):1700–1704. doi: 10.3748/wjg.v11.i11.1700

Table 2.

CD4/CD8 ratio, the percentage of CD16+56+ cells in post-transplanted AR group, post-transplanted stable group and healthy group.

Post-transplanted stable group (n = 15) Post-transplanted AR group (n = 15) Healthy group (n = 15)
CD4/CD8 1.5±0.5 1.8±0.4 1.5±0.2
CD16+56+ (%) 15.4±9.5 20.4±9.4 17.0±7.5